Axis TMS Revenue and Competitors

Detroit, MI USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Axis TMS's estimated annual revenue is currently $5.3M per year.(i)
  • Axis TMS's estimated revenue per employee is $229,600

Employee Data

  • Axis TMS has 23 Employees.(i)

Axis TMS's People

NameTitleEmail/Phone
1
Director Marketing And Public RelationsReveal Email/Phone
2
Accounting AdministratorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.8M60N/AN/AN/A
#2
$17M62N/AN/AN/A
#3
$31.9M21226%N/AN/A
#4
$14.5M53N/AN/AN/A
#5
$1054.8M2297N/AN/AN/A
#6
$2M20N/AN/AN/A
#7
$2.6M26N/AN/AN/A
#8
$0.2M3N/AN/AN/A
#9
$3.3M17N/AN/AN/A
#10
$11.2M46N/AN/AN/A
#11
$34M2187%$83.4MN/A
#12
$5.5M47N/AN/AN/A
#13
$12.7M49N/AN/AN/A
#14
$16M1109%N/AN/A
#15
$13.3M92N/AN/AN/A
#16
$2.1M21N/AN/AN/A
#17
$4.3M37N/AN/AN/A
#18
$0.9M10N/AN/AN/A
#19
$145.3M38115%N/AN/A
#20
$5M43N/AN/AN/A
Add Company

What Is Axis TMS?

keywords:N/A

N/A

Total Funding

23

Number of Employees

$5.3M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Axis TMS News

2022-04-17 - Renal hypoxia-HIF-PHD-EPO signaling in transition metal nephrotoxicity: friend or foe?

... and regulator of the hypoxia-PHD-HIF-EPO (HPHE) signaling axis, ... However, inadequate concentrations of essential TMs or entry of...

2022-04-06 - The Polyscore of autonomic parameters predicts mortality and ...

... 1.6 kHz, Pro-Tech, Porti system, TMS International). ... of patients at risk in the individual sub-groups are shown below the time axes.

2022-03-30 - Blue Yonder Named a Leader in the 2022 Gartner® Magic Quadrant™ for Transportation Management Systems Report, Positioned Furthest in Completeness of Vision for Sixth Year

Blue Yonder has been recognized as a Leader 11 consecutive times in the Gartner Magic Quadrant for TMS2. In the 2022 report, Blue Yonder was...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.3M230%N/A
#2
$3.7M23-8%N/A
#3
$2.3M230%N/A
#4
$4.7M23-32%N/A
#5
$4.3M23-12%N/A